Association of serum uric acid with Pro12Ala polymorphism in PPAR-γ2 among Chinese nonagenarians/centenarians

Aging Clinical and Experimental Research

Volumn 24, Issue 2, 2012, Pages 139-144

  Zhou, Yan ^a   Huang, Chang Quan ^a   Lu, Zhen Chan ^a   Dong, Bi Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Nonagenarians centenarians; Polymorphism in ppar 2; Pro12Ala; Serum uric acid

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRIACYLGLYCEROL; URIC ACID;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERURICEMIA; LONGEVITY; MAJOR CLINICAL STUDY; MALE; SMOKING; SYSTOLIC BLOOD PRESSURE; TEA; URIC ACID BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALANINE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; HYPERURICEMIA; MALE; POLYMORPHISM, GENETIC; PPAR GAMMA; PREVALENCE; PROLINE; URIC ACID;

EID: 84864525358     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
2. Daskalopoulou SS, Athyros VG, Kolovou GD, Anagnostopoulou KK, Mikhailidis DP. Definitions of metabolic syndrome: where are we now? Curr Vasc Pharmacol 2006; 4: 185-97. (Pubitemid 46785486)
3. Pacifico L, Cantisani V, Anania C et al. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol 2009; 160: 45-52.
4. Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 2006; 45: 605-14. (Pubitemid 43880913)
5. Wannamethee SG. Serum uric acid and risk of coronary heart disease. Curr Pharm Des 2005; 11: 4125-32 (Pubitemid 41672461)
6. Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. Domest Anim Endocrinol 2002; 22: 1-23. (Pubitemid 34438654)
7. Rocchi S, Auwerx J. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Ann Med 1999; 31: 342-51. (Pubitemid 29497696)
8. Walczak R, Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res 2002; 43: 177-86. (Pubitemid 34184004)
9. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005; 123: 993-9.
10. Rocchi S, Auwerx J. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Ann Med 1999; 31: 342-51. (Pubitemid 29497696)
11. Celi FS, Shuldiner AR. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity. Curr Diab Rep 2002; 2: 179-85.
12. Ollero M, Junaidi O, Zaman MM et al. Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/-mice. J Cell Physiol 2004; 200: 235-44. (Pubitemid 38880207)
13. Kallen CB, Lazar MA. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1996, 93, 5793-6. (Pubitemid 26191315)
14. Zhang B, Graziano MP, Doebber TW, Leibowitz MD et al. Down-regulation of the expression of the obese gene by antidiabetic thiazolidinediones in Zucker diabetic fatty rats and db/db mice. J Biol Chem 1996; 271: 9455-9. (Pubitemid 26139923)
15. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002; 51: 2341-7. (Pubitemid 34827380)
16. Tonjes A, Stumvoll M. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk. Curr Opin Clin Nutr Metab Care 2007; 10: 410-4. (Pubitemid 46934108)
17. Alevizaki M, Mantzou E, Cimponeriu A, Saltiki K, Philippou G, Wiersinga W. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO). Clin Endocrinol (Oxf) 2009; 70: 464-8.
18. Nelson TL, Fingerlin TE, Moss L, Barmada MM, Ferrell RE, Norris JM. The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado. Ann Nutr Metab 2007; 51: 252-7. (Pubitemid 47290388)
19. Yang LL, Hua Q, Liu RK, Yang Z. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. Arch Med Res 2009; 40: 89-96.
20. Argmann C, Dobrin R, Heikkinen S et al. PPARgamma2 is a key driver of longevity in the mouse. PLoS Genet 2009; 5: e1000752.
21. Erol A. The Functions of PPARs in aging and longevity. PPAR Res 2007; 2007: 39654.
22. Yue JR, Dong BR, Huang CQ, Lu ZC, Wu HM, Zhang YL. Pro12Ala polymorphism in PPAR-γ2 and dementia in Chinese nonagenarians/centenarians. AGE doi 10.1007/s11357-010-9132-1.
23. Huang CQ, Dong BR, Zhang YL, Wu HM, Liu QX, Flaherty JH. Cognitive impairment and hypertension among Chinese nonagenarians and centenarians. Hypertens Res 2009; 32: 554-8.
24. Huang CQ, Dong BR, Wu HM, Zhang YL. Association of Cognitive Impairment with Serum Lipid/Lipoprotein among Chinese Nonagenarians and Centenarians. Dementia Geriatr Cogn Disord 2009; 27: 111-6.
25. Huang CQ, Dong BR, Zhang YL, Wu HM. Association of cognitive impairment with Smoking, Alcohol consumption, Tea consumption and Exercise among Chinese Nonagenarians/Centenarians. Cogn Behav Neurol 2009; 22: 190-6.
26. Meirhaeghe A, Boreham CAG, Murray LJ et al. A possible role for the PPARG Pro12Ala polymorphism in preterm birth. Diabetes 2007; 56: 494-8.